ubmslateRN-logo-ubm

RN Mobile Menu

Topics:

Rheumatology Network

Overactive Immune System Linked to Specific Triggers

The little-understood antibody immunoglobulin E (IgE) plays a previously unknown role in systemic lupus erythematosus, new research shows.
 
(©Wallybird/Shutterstock.com)

Recent Content

©SebastianKaulitzki/Shutterstock.com

Psoriatic arthritis is an independent risk factor for cardiovascular disease, according to a new meta-analysis.

©Zonda/Shutterstock.com

A new modeling study suggests that the opioid medications tramadol and oxycodone are not generally cost-effective for knee osteoarthritis.

©PhuShutter/Shutterstock.com

Patients with spondyloarthritis can confidently undergo treatment with tumor necrosis factor ⍺ inhibitors (TNFi) without fear of cancer risk.

©SebastianKaulitzki2/Shutterstock.com

Many new treatments for axial spondyloarthritis (SpA) have been introduced in recent years. This review summarizes current treatments for SpA.

©ImagePointFr/Shutterstock.com

Initial combination therapy leads to faster clinical improvements in early rheumatoid arthritis making drug-free remission a realistic outcome.

©AlilaMedicalMedia/Shutterstock.com

For patients with gout, new evidence suggests arhalofenate can be used to safely prevent flare-ups, as well as reduce serum levels.

Rituximab might even be effective for forms of Lupus that resist standard treatments.

By clicking Accept, you agree to become a member of the UBM Medica Community.